Óliver Pérez

Preliminary Assessment of the Safety and Immunogenicity of a New CTXΦ-Negative, Hemagglutinin/Protease-Defective El Tor Strain as a Cholera Vaccine Candidate

Jorge A. Benítez, Luis Garcı́a, Anisia Silva et al. · Infection and Immunity · 1999 · 98 citations · Full text

The Vaccine Candidate <i>Vibrio cholerae</i> 638 Is Protective against Cholera in Healthy Volunteers

Luis Eugenio Valdés García, Manuel Díaz Jidy, Hilda Garcı́a et al. · Infection and Immunity · 2005 · 94 citations · Full text

Diarrheal Stool, Immunology, Is Protective +17

New Vaccines Require Potent Adjuvants like AFPL1 and AFCo1

Óliver Pérez, Miriam Lastre, Osmir Cabrera et al. · Scandinavian Journal of Immunology · 2007 · 57 citations

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice

Reinaldo Acevedo, Adriana Callicó, Judith del Campo et al. · Methods · 2009 · 32 citations

Inflammation, Intranasal Administration, Microbial Pathogens +7

A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice

José Luis Pérez, Reinaldo Acevedo, Adriana Callicó et al. · Vaccine · 2008 · 29 citations

Mucosal Vaccination, Vibriocidal Antibodies, Medicine +5